Best TWAS P=2.060363e-11 · Best GWAS P=7.81679e-13 conditioned to 0.00411055
# | Tissue | Gene | Modality | RNA phenotype | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Adipose | Fndc3a | alternative TSS | ENSRNOT00000101367 | 0.05 | 0.02 | blup | 2041 | 0.04 | 2.7e-05 | 5.4 | 6.5 | 8.7e-11 | 0.84 | 0.69 | 0.30 | FALSE |
2 | Adipose | Fndc3a | alternative TSS | ENSRNOT00000111875 | 0.05 | 0.02 | blup | 2041 | 0.03 | 1.4e-04 | 5.4 | -6.5 | 7.9e-11 | -0.84 | 0.55 | 0.42 | FALSE |
3 | Adipose | Fndc3a | alternative TSS | ENSRNOT00000101367 | 0.06 | 0.02 | blup | 2041 | 0.04 | 2.1e-05 | 5.4 | 6.5 | 1.0e-10 | 0.84 | 0.73 | 0.26 | FALSE |
4 | Adipose | Fndc3a | alternative TSS | ENSRNOT00000111875 | 0.05 | 0.02 | blup | 2041 | 0.03 | 1.0e-04 | 5.4 | -6.5 | 8.8e-11 | -0.84 | 0.58 | 0.39 | FALSE |
5 | Adipose | Itm2b | gene expression | ENSRNOG00000016271 | 0.10 | 0.10 | blup | 1980 | 0.10 | 3.3e-11 | 5.2 | 5.3 | 9.0e-08 | 0.68 | 0.42 | 0.58 | FALSE |
6 | Adipose | Fndc3a | intron excision ratio | chr15:47755611:47801368 | 0.04 | 0.02 | top1 | 1 | 0.03 | 8.4e-04 | 5.4 | -5.4 | 6.7e-08 | -0.78 | 0.08 | 0.03 | FALSE |
7 | Adipose | Fndc3a | intron excision ratio | chr15:47832616:47866529 | 0.03 | 0.01 | enet | 6 | 0.01 | 1.2e-02 | 5.4 | -6.7 | 2.1e-11 | -0.83 | 0.61 | 0.10 | TRUE |
8 | Adipose | Rcbtb2 | intron excision ratio | chr15:48333445:48336229 | 0.15 | 0.15 | blup | 2077 | 0.15 | 2.4e-16 | 5.5 | 5.2 | 1.6e-07 | 0.71 | 0.42 | 0.58 | FALSE |
9 | Adipose | Rb1 | mRNA stability | ENSRNOG00000016029 | 0.09 | 0.08 | top1 | 1 | 0.08 | 1.3e-09 | 5.4 | 5.4 | 8.3e-08 | 0.71 | 0.36 | 0.64 | FALSE |
10 | BLA | Itm2b | gene expression | ENSRNOG00000016271 | 0.24 | 0.12 | top1 | 1 | 0.12 | 3.7e-07 | 5.2 | 5.2 | 1.9e-07 | 0.65 | 0.50 | 0.44 | FALSE |
11 | BLA | Nudt15 | gene expression | ENSRNOG00000025239 | 0.07 | 0.04 | top1 | 1 | 0.04 | 2.2e-03 | 5.2 | -5.2 | 2.0e-07 | -0.69 | 0.09 | 0.05 | FALSE |
12 | BLA | Rb1 | mRNA stability | ENSRNOG00000016029 | 0.10 | 0.07 | top1 | 1 | 0.07 | 1.5e-04 | 5.4 | -5.4 | 7.4e-08 | -0.68 | 0.09 | 0.06 | FALSE |
13 | Brain | Fndc3a | gene expression | ENSRNOG00000014478 | 0.05 | 0.00 | blup | 2041 | 0.01 | 2.7e-02 | -4.4 | -5.8 | 5.1e-09 | -0.72 | 0.76 | 0.15 | FALSE |
14 | Brain | Med4 | gene expression | ENSRNOG00000017170 | 0.08 | 0.10 | top1 | 1 | 0.10 | 1.9e-09 | 5.4 | -5.4 | 6.9e-08 | -0.69 | 0.23 | 0.77 | FALSE |
15 | Brain | Nudt15 | gene expression | ENSRNOG00000025239 | 0.12 | 0.13 | top1 | 1 | 0.13 | 1.7e-12 | 5.1 | -5.1 | 3.2e-07 | -0.68 | 0.54 | 0.46 | FALSE |
16 | Brain | Itm2b | mRNA stability | ENSRNOG00000016271 | 0.10 | 0.06 | lasso | 3 | 0.07 | 1.1e-06 | 5.4 | -5.4 | 5.5e-08 | -0.62 | 0.54 | 0.46 | FALSE |
17 | IL | Rb1 | gene expression | ENSRNOG00000016029 | 0.19 | 0.05 | top1 | 1 | 0.05 | 2.6e-02 | 5.1 | -5.1 | 2.8e-07 | -0.68 | 0.11 | 0.05 | FALSE |
18 | IL | Itm2b | gene expression | ENSRNOG00000016271 | 0.43 | 0.26 | top1 | 1 | 0.26 | 6.5e-07 | 5.2 | 5.2 | 2.2e-07 | 0.70 | 0.26 | 0.18 | FALSE |
19 | Liver | Rcbtb2 | mRNA stability | ENSRNOG00000015054 | 0.26 | 0.24 | blup | 2077 | 0.26 | 3.7e-28 | 5.6 | -5.4 | 5.0e-08 | -0.69 | 0.37 | 0.63 | FALSE |
20 | NAcc | Itm2b | gene expression | ENSRNOG00000016271 | 0.32 | 0.23 | enet | 5 | 0.26 | 1.5e-06 | 5.2 | 5.4 | 5.7e-08 | 0.60 | 0.38 | 0.57 | FALSE |
21 | NAcc2 | Itm2b | gene expression | ENSRNOG00000016271 | 0.42 | 0.11 | top1 | 1 | 0.11 | 1.0e-06 | 5.2 | 5.2 | 1.9e-07 | 0.70 | 0.45 | 0.39 | FALSE |
22 | OFC | Rb1 | gene expression | ENSRNOG00000016029 | 0.18 | 0.10 | top1 | 1 | 0.10 | 2.6e-03 | 5.4 | -5.4 | 6.7e-08 | -0.69 | 0.11 | 0.06 | FALSE |
23 | OFC | Itm2b | gene expression | ENSRNOG00000016271 | 0.18 | 0.08 | top1 | 1 | 0.08 | 6.0e-03 | 5.2 | 5.2 | 2.1e-07 | 0.59 | 0.10 | 0.05 | FALSE |
24 | PL2 | Rb1 | mRNA stability | ENSRNOG00000016029 | 0.44 | 0.05 | top1 | 1 | 0.06 | 6.1e-04 | 5.5 | -5.5 | 4.0e-08 | -0.65 | 0.09 | 0.09 | FALSE |
h2: Heritability estimate for the given transcriptomic model. PP3: Posterior probability of two distinct causal variants. PP4: Posterior probability of a single shared causal variant. joint: Whether the RNA phenotype is in the joint model.